Tg Therapeutics (TGTX) Gross Margin (2021 - 2026)
Tg Therapeutics (TGTX) posted quarterly Gross Margin of 83.65% for Q1 2026, down 349.0% year-over-year from 33.59% in Q1 2025, and up 4.31% quarter-over-quarter from 80.19% in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) Gross Margin (2021 - 2026) Analysis & Trends
Tg Therapeutics' Gross Margin history runs 6 years deep, the most recent figure standing at 83.65% for Q1 2026.
- In Q1 2026, Gross Margin fell 349.0% year-over-year to 83.65%; the TTM figure through Mar 2026 stood at 83.05% (down 437.0% YoY), while the FY2025 annual figure was 83.66%, down 464.0% from the prior year.
- Gross Margin for Q1 2026 stood at 83.65%, up from 80.19% in the prior quarter.
- The five-year high for Gross Margin was 97.88% in Q3 2023, with the low at 80.19% in Q4 2025.
- The 5-year median for Gross Margin is 88.11% (2023), against an average of 88.41%.
- The sharpest annual moves came in 2023 and 2024: Gross Margin sank 1411 bps in 2023, then jumped 363 bps in 2024.
- Tg Therapeutics' Gross Margin stood at 96.25% in 2022, then decreased by 15 bps to 82.14% in 2023, then rose by 4 bps to 85.77% in 2024, then slipped by 6 bps to 80.19% in 2025, then grew by 4 bps to 83.65% in 2026.
- Business Quant data shows TGTX's Gross Margin at 83.65% in Q1 2026, 80.19% in Q4 2025, and 82.63% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 82.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.86% |
| Mar 31, 2026 | 83.65% |
| Dec 31, 2025 | 80.19% |
| Sep 30, 2025 | 82.63% |
| Jun 30, 2025 | 86.58% |
| Mar 31, 2025 | 87.14% |
| Dec 31, 2024 | 85.77% |
| Sep 30, 2024 | 88.86% |
| Jun 30, 2024 | 88.70% |
| Mar 31, 2024 | 91.43% |
| Dec 31, 2023 | 82.14% |
| Sep 30, 2023 | 97.88% |
| Jun 30, 2023 | 88.11% |
| Mar 31, 2023 | 89.02% |
| Dec 31, 2022 | 96.25% |
| Sep 30, 2022 | 97.87% |
| Mar 31, 2021 | 82.47% |